 Aged
"Aged" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.
| Descriptor ID |
D000368
|
| MeSH Number(s) |
M01.060.116.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged".
Below are MeSH descriptors whose meaning is more specific than "Aged".
This graph shows the total number of publications written about "Aged" by people in this website by year, and whether "Aged" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 106 | 106 | | 1996 | 0 | 110 | 110 | | 1997 | 0 | 132 | 132 | | 1998 | 1 | 122 | 123 | | 1999 | 0 | 133 | 133 | | 2000 | 3 | 172 | 175 | | 2001 | 1 | 115 | 116 | | 2002 | 0 | 113 | 113 | | 2003 | 1 | 252 | 253 | | 2004 | 3 | 270 | 273 | | 2005 | 1 | 340 | 341 | | 2006 | 2 | 360 | 362 | | 2007 | 1 | 406 | 407 | | 2008 | 0 | 442 | 442 | | 2009 | 0 | 500 | 500 | | 2010 | 1 | 542 | 543 | | 2011 | 0 | 580 | 580 | | 2012 | 0 | 618 | 618 | | 2013 | 0 | 683 | 683 | | 2014 | 0 | 730 | 730 | | 2015 | 2 | 789 | 791 | | 2016 | 0 | 796 | 796 | | 2017 | 0 | 854 | 854 | | 2018 | 0 | 895 | 895 | | 2019 | 1 | 969 | 970 | | 2020 | 0 | 759 | 759 | | 2021 | 0 | 734 | 734 | | 2022 | 0 | 320 | 320 | | 2023 | 0 | 286 | 286 | | 2024 | 0 | 120 | 120 | | 2025 | 0 | 7 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Aged" by people in Profiles.
-
Voorhees TJ, McLaughlin EM, Torka P, Florindez J, Kim NH, Moyo TK, Reves H, Sumransub N, Deshpande S, Rose A, Duarte C, Faisal MS, Hamid S, Subbiah S, Ayyappan S, Shea L, Cortese M, Patel K, Major A, Saeed H, Svoboda J, Desai S, Geethakumari PR, Hamadani M, Grover N, Epperla N. Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers. Blood Cancer J. 2025 Mar 26; 15(1):45.
-
Inamo J, Keegan J, Griffith A, Ghosh T, Horisberger A, Howard K, Pulford JF, Murzin E, Hancock B, Dominguez ST, Gurra MG, Gurajala S, Jonsson AH, Seifert JA, Feser ML, Norris JM, Cao Y, Apruzzese W, Bridges SL, Bykerk VP, Goodman S, Donlin LT, Firestein GS, Bathon JM, Hughes LB, Filer A, Pitzalis C, Anolik JH, Moreland L, Hacohen N, Guthridge JM, James JA, Cuda CM, Perlman H, Brenner MB, Raychaudhuri S, Sparks JA, Holers VM, Deane KD, Lederer J, Rao DA, Zhang F. Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis. J Clin Invest. 2025 Mar 17; 135(6).
-
Schaich CL, Chappell MC, Shotwell MS, Joly MM, Gibbs KW, Barksdale A, Douglas IS, Chen P, Levitt JE, Puskarich MA, Rice TW, Harkins MS, Hudock KM, Lanspa MJ, Ginde AA, Self WH, Collins SP, Files DC. The circulating renin-angiotensin system and mortality among patients hospitalized for COVID-19: a mechanistic substudy of the ACTIV-4 Host Tissue trials. Am J Physiol Lung Cell Mol Physiol. 2025 Mar 01; 328(3):L405-L412.
-
Jacobson CL, Choudhury R, Broad A, Maw AM, Wolf C, Adams B, Drabkin A. Understanding and promoting equitable post-discharge care in firearm injury survivors: a retrospective chart review. Sci Rep. 2025 Jan 29; 15(1):3718.
-
Rauzi MR, Abbate LM, Lum HD, Cook PF, Stevens-Lapsley JE. Multicomponent telerehabilitation programme for older veterans with multimorbidity: a programme evaluation. BMJ Mil Health. 2025 Jan 28; 171(1):33-39.
-
Borgers JSW, Lenkala D, Kohler V, Jackson EK, Linssen MD, Hymson S, McCarthy B, O'Reilly Cosgrove E, Balogh KN, Esaulova E, Starr K, Ware Y, Klobuch S, Sciuto T, Chen X, Mahimkar G, Sheen JHF, Ramesh S, Wilgenhof S, van Thienen JV, Scheiner KC, Jedema I, Rooney M, Dong JZ, Srouji JR, Juneja VR, Arieta CM, Nuijen B, Gottstein C, Finney OC, Manson K, Nijenhuis CM, Gaynor RB, DeMario M, Haanen JB, van Buuren MM. Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial. Nat Med. 2025 Mar; 31(3):881-893.
-
McDermott GC, Hayashi K, Yoshida K, Juge PA, Moll M, Cho MH, Doyle TJ, Kinney GL, Dellaripa PF, Wallace ZS, Regan EA, Hunninghake GM, Silverman EK, Ash SY, Estepar RSJ, Washko GR, Sparks JA. Rheumatoid arthritis, quantitative parenchymal lung features and mortality among smokers. Rheumatology (Oxford). 2025 Jan 01; 64(1):133-142.
-
Thompson Iii GR, Chastain DB, Ferraz C, Alhayek S, Salinas JL, Sillau S, Stenehjem EA, Henao-Mart?nez AF. Mortality patterns in candidemia: Insights from a multispecies analysis using a global research network. Med Mycol. 2024 Dec 27; 63(1).
-
Garbin AJ, Falvey JR, Cumbler E, Derlein D, Currier D, Nordon-Craft A, Will R, Olivos M, Forster JE, Mangione KK, Stevens-Lapsley JE. Progressive Multicomponent Intervention for Older Adults in Home Health Settings Following Hospitalization: Randomized Clinical Trial. Phys Ther. 2024 Dec 06; 104(12).
-
Collins SP, Shotwell MS, Strich JR, Gibbs KW, de Wit M, Files DC, Harkins M, Hudock K, Merck LH, Moskowitz A, Apodaca KD, Barksdale A, Safdar B, Javaheri A, Sturek JM, Schrager H, Iovine NM, Tiffany B, Douglas I, Levitt J, Ginde AA, Hager DN, Shapiro N, Duggal A, Khan A, Lanspa M, Chen P, Gentile N, Harris E, Gong M, Sellers S, Goodwin AJ, Tidswell MA, Filbin M, Desai N, Guti?rrez F, Estrada V, Burgos J, Boyles T, Pa?o-Pardo JR, Hussen N, Rosenberg Y, Troendle J, Bernard GR, Bistran-Hall AJ, Walsh K, Casey JD, DeClercq J, Joly MM, Pulley J, Rice TW, Schildcrout JS, Wang L, Semler MW, Self WH. Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical Trial. JAMA Netw Open. 2024 Dec 02; 7(12):e2448215.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|